It should be noted that 23 (28,75%) of multiple myeloma patients (of which only 2 in the early stages of disease) had IL–6 pos.–174 GG genotype and this genotype was associated with increased serum levels of IL–6 (Figure 2). Here, IL6 is linked to AL amyloidosis.